EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Anti‐BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis

Nadège Cordel iD, Jasmine Flament, Fabienne Jouen, Vannina Seta, Emmanuelle Tancrède-Bohin, Catherine Picard Dahan, Maria-Polina Konstantinou iD, Olivier Dereure iD, Gaëlle Quéreux, Catherine Prost, Christophe Bedane, Sébastien Debarbieux und 31 weitere

Journal of the European Academy of Dermatology and Venereology · 2023

DOI: 10.1111/jdv.18973 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von Nadège Cordel und 42 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Clinical Immunology, Guadeloupe University Hospital, Pointe-à-Pitre, Guadeloupe. Hauptthemen laut MEDLINE: Pemphigoid Gestationis, Pemphigoid, Bullous, Premature Birth. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Adverse pregnancy outcomes (APO) occur in 35% of patients with pemphigoid gestationis (PG). No biological predictor of APO has been established yet.

Objectives

To assess a potential relationship between the occurrence of APO and the serum value of anti‐BP180 antibodies at the time of PG diagnosis.

Methods

Multicentre retrospective study conducted from January 2009 to December 2019 in 35 secondary and tertiary care centres. Inclusion criteria: (i) diagnosis of PG according to clinical, histological and immunological criteria, (ii) ELISA measurement of anti‐BP180 IgG antibodies determined at the time of PG diagnosis with the same commercial kit and (iii) obstetrical data available.

Results

Of the 95 patients with PG included, 42 had one or more APO, which mainly corresponded to preterm birth ( n = 26), intrauterine growth restriction (IUGR) ( n = 18) and small weight for gestational age at birth ( n = 16). From a ROC curve, we identified a threshold of 150 IU ELISA value as the most discriminating to differentiate between patients with or without IUGR, with 78% sensitivity, 55% specificity, 30% positive and 91% negative predictive value. The threshold >150 IU was confirmed using a cross‐validation based on bootstrap resampling, which showed that the median threshold was 159 IU. Upon adjusting for oral corticosteroid intake and main clinical predictors of APO, an ELISA value of >150 IU was associated with the occurrence of IUGR (OR = 5.11; 95% CI: 1.48–22.30; p = 0.016) but not with any other APO. The combination of blisters and ELISA values higher than 150 IU led to a 2.4‐fold higher risk of all‐cause APO (OR: 10.90; 95% CI: 2.33–82.3) relative to patients with blisters but lower values of anti‐BP180 antibodies (OR of 4.54; 95% CI 0.92–34.2).

Conclusion

These findings suggest that anti‐BP180 antibody ELISA value in combination with clinical markers is helpful in managing the risk of APO, in particular IUGR, in patients with PG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pemphigoid GestationisPemphigoid, BullousPremature BirthPregnancyFemaleHumansInfant, NewbornRetrospective StudiesBlisterPregnancy OutcomeNon-Fibrillar CollagensEnzyme-Linked Immunosorbent AssayImmunoglobulin GAutoantigensAutoantibodies

Substanzen

Non-Fibrillar CollagensImmunoglobulin GAutoantigensAutoantibodies

Autor:innen und Institutionen

  • Department of Dermatology and Clinical Immunology, Guadeloupe University Hospital, Pointe-à-Pitre, Guadeloupe.
  • Univ Rouen Normandie, FOCIS Center of Excellence PAn'THER, Rouen, France.
  • Department of Dermatology, Rouen University Hospital, Rouen, France.
  • Department of Immunology and biotherapies, Rouen University Hospital, Rouen, France.
  • Department of Dermatology, Cochin Hospital AP-HP, Paris, France.
  • Department of Dermatology, Saint Louis Hospital AP-HP, Paris, France.

ORCID-Profile: Nadège Cordel, Maria-Polina Konstantinou, Olivier Dereure, Saskia Ingen Housz Oro, Anne Pham-Ledard, Laurent Machet, Pascal Joly

Zitieren

APA

Cordel, N., Flament, J., Jouen, F., Seta, V., Tancrède-Bohin, E., Dahan, C. P., Konstantinou, M. P., Dereure, O., Quéreux, G., Prost, C., Bedane, C., Debarbieux, S., Lacour, J. P., Dompmartin, A., Wierzbicka-Hainaut, E., Villada, I. B., Oro, S. I. H., Vabres, P., Richard, M. A., …, & French study Group on autoimmune bullous skin diseases (2023). Anti‐BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.18973

Vancouver

Cordel N, Flament J, Jouen F, Seta V, Tancrède-Bohin E, Dahan CP, et al. Anti‐BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.18973

BibTeX
@article{Cordel2023,
  author = {Cordel, Nadège and Flament, Jasmine and Jouen, Fabienne and Seta, Vannina and Tancrède-Bohin, Emmanuelle and Dahan, Catherine Picard and Konstantinou, Maria-Polina and Dereure, Olivier and Quéreux, Gaëlle and Prost, Catherine and Bedane, Christophe and Debarbieux, Sébastien and Lacour, Jean-Philippe and Dompmartin, Anne and Wierzbicka-Hainaut, Ewa and Villada, Isabelle Bourgault and Oro, Saskia Ingen Housz and Vabres, Pierre and Richard, Marie-Aleth and Delaporte, Emmanuel and Pham-Ledard, Anne and Leccia, Marie-Thérèse and Litrowski, Noémie and Michel, Catherine and Lagrange, Brigitte and D'Incan, Michel and Abasq, Claire and Duvert-Lehembre, Sophie and Dupuy, Alain and Alcaraz, Isabelle and Breton-Guitarian, Anne-Laure and Lombart, Florian and Estève, Eric and Machet, Laurent and Del Giudice, Pascal and Fenot, Marion and Belmondo, Thibaut and Morin, Florence and Guérin, Olivia and Benichou, Jacques and Tressières, Benoît and Joly, Pascal and French study Group on autoimmune bullous skin diseases, French study Group on autoimmune bullous skin diseases},
  title = {Anti‐BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2023},
  doi = {10.1111/jdv.18973}
}
Kostenlos starten →